CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation

Lung Cancer ◽  
2014 ◽  
Vol 85 (2) ◽  
pp. 147-151 ◽  
Author(s):  
Kenichi Suda ◽  
Hiroshi Mizuuchi ◽  
Isao Murakami ◽  
Hidetaka Uramoto ◽  
Fumihiro Tanaka ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document